Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs  by Cawley, Simon et al.
Cell, Vol. 116, 499–509, February 20, 2004, Copyright 2004 by Cell Press
Unbiased Mapping of Transcription Factor Binding
Sites along Human Chromosomes 21 and 22 Points
to Widespread Regulation of Noncoding RNAs
and assembled with the near completed draft of the
human genome (Lander et al., 2001; Venter et al., 2001).
Recently, there have been several reports based on em-
pirical and computational evidence indicating that the
transcriptome is larger and more complex than first con-
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tions of RNA transcription along human chromosomesGregg Helt,1 Kevin Struhl,2,*
21 and 22 using cytoplasmic, poly(A) RNA from a col-and Thomas R. Gingeras1,*
lection of 11 developmentally diverse cell lines (Kapra-1Affymetrix
nov et al., 2002). These maps indicated that there is as3380 Central Expressway
much as an order of magnitude more transcription alongSanta Clara, California 95051
these two chromosomes than could be accounted for by2Deptartment of Biological Chemistry
the then current genomic annotations of protein codingand Molecular Pharmacology
RNAs, suggesting a hitherto hidden population of RNAHarvard Medical School
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these novel transcripts revealed that they possess little3Department of Biological Sciences
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scripts. Similar results were presented in two reports4 Genome Institute of Singapore
describing the results of in depth serial analysis of geneSingapore 138672
expression (SAGE) of a collection of cDNA libraries
(Chen et al., 2002; Saha et al., 2002), and most recently
using arrays of serial PCR fragments covering the nonre-Summary
petitive human chromosome 22 genomic sequences
(Rinn et al., 2003). We will refer to this general groupUsing high-density oligonucleotide arrays represent-
of unannotated RNAs as noncoding, although some ofing essentially all nonrepetitive sequences on human
these RNAs are likely to encode short proteins.chromosomes 21 and 22, we map the binding sites in
Interestingly, the comparative sequence analysis ofvivo for three DNA binding transcription factors, Sp1,
the recently completed mouse genome with the humancMyc, and p53, in an unbiased manner. This mapping
genome resulted in an unexpected observation that isreveals an unexpectedly large number of transcription
consistent with these previous empirical observationsfactor binding site (TFBS) regions, with a minimal esti-
(Waterston et al., 2002). Comparative analyses of themate of 12,000 for Sp1, 25,000 for cMyc, and 1600 for
mouse genome revealed that there is almost two timesp53 when extrapolated to the full genome. Only 22%
more evolutionary sequence conservation observedof these TFBS regions are located at the 5 termini of
than expected and that these conserved sequence re-protein-coding genes while 36% lie within or immedi-
gions are located distal from the well-annotated exons.
ately 3 to well-characterized genes and are signifi-
Dermitzakis et al. have also analyzed a subsection of
cantly correlated with noncoding RNAs. A significant
the conserved murine and human sequences found on
number of these noncoding RNAs are regulated in human chromosome 21 (mouse chromosomes 10,16,17)
response to retinoic acid, and overlapping pairs of for evidence of transcription emanating from these re-
protein-coding and noncoding RNAs are often coregu- gions (Dermitzakis et al., 2002). Approximately 37%
lated. Thus, the human genome contains roughly com- (837) of the conserved sequence regions (100 bp and
parable numbers of protein-coding and noncoding 70% identity) on chromosomes 10, 16, and 17 were
genes that are bound by common transcription factors determined to be transcribed. Most recently, analysis
and regulated by common environmental signals. by the FANTOM consortium and the RIKEN genome
research group of the mouse transcriptome revealed
Introduction that 15,923 of the 60,770 full-length clones that they
isolated are novel, with 11,665 (73%) of these being
The transcriptome of the human genome is composed noncoding transcripts (Okazaki et al., 2002). A total of
of discrete RNA molecules serving multiple functions 2,431 of these reported transcripts were noted as anti-
including encoding protein information, signaling, struc- sense transcripts. These empirical and computational
tural support of subcellular elements, and transcrip- findings all point to a large and as yet poorly understood
tional and posttranscriptional regulatory agents. A con- population of RNAs in the transcriptome. At present,
siderable amount of information concerning the protein however, functional attributes of these RNAs have yet
coding transcripts of the genome has been collected to be demonstrated.
The high-density, tiled arrays used to map the RNA
transcripts along human chromosomes 21 and 22 con-*Correspondence: tom_gingeras@affymetrix.com (T.R.G.), Kevin@
tain on average one oligonucleotide pair every 35 bphms.harvard.edu (K.S.)
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of these chromosomes. In combination with chromatin differential hybridization (Supplemental Figure S1 at htt
p://www.cell.com/cgi/content/full/116/4/499/DC1).immunoprecipitation (ChIP), these arrays should permit
the identification of physiological target sites of tran- Considering the stringency of the threshold used, the
true number of sites is expected to be even larger. Thesescriptional regulatory proteins in an unbiased and com-
prehensive manner. ChIP has been used to analyze the 1157 TFBS were identified by comparing the results
of the binding experiments for each TF to two controllocation of transcriptional regulatory proteins in yeast
cells using arrays with PCR products containing all in- experiments. In one set of control experiments, the im-
munoprecipitation step was omitted, in another set, antergenic regions (Horak et al., 2002a; Iyer et al., 2001;
Lee et al., 2002; Ng et al., 2002; Ren et al., 2000; Simon antibody to bacterial GST was employed (instead of an
antibody against a transcription factor). A total of 64%et al., 2001; Zeitlinger et al., 2003). However, the few
papers combining ChIP and microarrays in mammalian of the TFBSs were commonly identified using both con-
trols. Extrapolating these findings to the whole genomecells have involved selected upstream regions (Horak
et al., 2002b; Mao et al., 2003; Ren et al., 2002) and predicts a total of about 12,000 Sp1 sites, 25,000 cMyc
sites, and 1600 p53 sites.hence do not address the possibility of transcription
factor binding sites in other locations. This issue is par- Verification by quantitative PCR was performed on a
sample of the TFBS, confirming 11 of 11 p53, 6 of 6ticularly relevant in mammalian cells because the mRNA
and protein coding sequences represent a small per- Sp1, and 4 of 4 cMyc binding sites (Supplemental Table
S1 on Cell website). An additional 3 of 3 p53 sites werecentage of the total genome and because transcriptional
regulatory proteins can function at long and variable confirmed using a different antibody, p53_DO1, which
reacts with an N-terminal epitope (Supplemental Tabledistances from transcriptional initiation sites.
To further explore properties of the transcriptome and S1 online). The TFBS detected with p53_DO1 strongly
overlap those detected with the p53 full-length antibodyto identify functional attributes of the noncoding tran-
scripts, binding sites for a collection of transcription (20 of the 48 p53 TFBS were also detected with
p53_DO1). These results provide direct experimental ev-factors have been mapped along chromosomes 21 and
22 in an unbiased approach, as a means of identifying idence that very few of the identified TFBS are false posi-
tives.possible regulatory regions for a wide variety of cellular
RNAs. Interestingly, only 22% of the transcription factor
binding sites (TFBS) are located at the canonical 5 ter- Properties of Transcription Factor Binding Sites
mini of well-characterized protein-coding genes, while For each TFBS, we examined the immunoprecipitated
36% lie within of immediately 3 to well-characterized DNA fragments for characteristics associated with tran-
genes and are significantly correlated with noncoding scriptional regulatory regions (proximity to CpG islands
RNAs. A number of these noncoding RNAs are regulated and annotated 5 exons and the presence of known
in response to retinoic acid stimulation, and coregula- binding motifs). A total of 43%, 24%, and 17% of the
tion of overlapping pairs of protein-coding and noncod- Sp1, cMyc, and p53 TFBS, respectively, were within 1
ing RNAs occurs at a frequency significantly greater Kb of an annotated CpG island (Table 1A), constituting
than chance. These data point to evidence that protein approximately 5.5-, 3.1-, and 2.1-fold enrichment, re-
coding and noncoding genes have similar functional spectively, over what would be expected at random.
attributes regarding (1) the existence of common tran- Enrichment for location proximal to 5 exons was found
scription factors in their promoter regions and (2) their for Sp1 and cMyc, but not for p53 (Table 1B). Analyses
ability to respond to environmental and developmental of the TFBS for the presence of known TF binding motifs
conditions, which together suggest that that they may demonstrated substantial enrichment for all three TFs.
be controlled by the same transcriptional regulatory ma- In the case of p53, because of the almost complete
chinery. These functional attributes argue against the lack of matches to the exact consensus and with the
idea that these noncoding RNAs merely represent tran- availability of a weight matrix from an independent study
scriptional noise, but instead suggest that they may (Hoh et al., 2002), a search for inexact matches was
have biological functions. implemented. As much as 62% of the p53 sites contain
evidence for a p53 consensus sequence (greater than
3-fold enrichment over what would be expected at ran-Results
dom). Using the motif finder, MDscan (Liu et al., 2002),
the exact Sp1 consensus is recovered along with manyIdentification of Transcription Factor Binding
Sites along Chromosomes 21 and 22 slightly weaker variants that may well bind Sp1 (data
not shown). The lack of identifiable binding motifs atBy combining chromatin immunoprecipitation and high-
density oligonucleotide arrays interrogating the nonre- some of the sites may be explained by the existence of
as yet unidentified binding motifs, indirect interactionspeat genomic sequences of chromosomes 21 and 22
at 35 base pair (bp) resolution (Kapranov et al., 2002), with DNA mediated by other proteins, or, potentially,
crossreactivity of antibodies with other DNA bindingthe positions of binding for three human transcription
factors (TFs), cMyc, Sp1, and p53, were determined proteins.
Other observations that follow from the mapping ofwithin two cell lines (cMyc and Sp1 in Jurkat, p53 in
HCT1116). A total of 353, 756, and 48 high confidence TFBS for Sp1, cMyc, and p53 along chromosomes 21
and 22 are: (1) 61% of the 353 Sp1 sites overlapped(p value  105) binding sites were observed for Sp1,
cMyc, and p53, respectively (all data is accessible at predicted cMyc sites and 29% of the 756 cMyc sites
overlapped an Sp1 site, suggesting coincident bindinghttp://transcriptome.affymetrix.com/publication/tfbs). At
this stringent threshold, it is estimated that on the order and possible coregulation at these sites. (2) The large
majority of the 22% TFBS regions located at the 5 endof one or less of the TFBS regions is falsely detecting
Transcription Factors on Chromosomes 21 and 22
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Table 1. Enrichment for Promoter Characteristics Found at Predicted TFBS
(A) CpG Islands
# Sites within % Sites within Fold-
TFBS # Sites 1 Kb of CpG 1 Kb of CpG Enrichment
Sp1 353 152 43 5.5
cMyc 756 182 24 3.1
P53 48 8 17 2.1
(B) 5 Exons
# Sites within % Sites within Fold-
TFBS # Sites 1 Kb of 5 Exon 1 Kb of 5 Exon Enrichment
Sp1 353 95 27 5.5
cMyc 756 137 18 3.7
P53 48 0 0 0
(C) Consensus Binding Motifs
# Sites with % Sites with # Motifs Expected
TFBS # Sites # Motifs  1 Motif  1 Motif at Random Fold-Enrichment
Sp1 353 124 76 22 22 5.6
cMyc 756 611 259 33 269 2.3
P53 48 1 1 2 0.06 16.6
The proximity of predicted TFBS to CpG islands and well-characterized 5 exons is summarized in Tables 1A and 1B. CpG island annotations
were taken from the June 2002 assembly of the human genome at UCSC and 5 exon annotations were taken from RefSeq and GenBank
mRNA records annotated as having “complete CDS.” Distance between a predicted TFBS and a CpG island or a 5 exon is defined as the
separation between their nearest ends. The fold enrichment is calculated by comparison with sites generated at random uniformly over the
nonrepetitive regions of chromosomes 21 and 22. 7.9% of the randomly generated sites were located within 1 Kb of CpG islands, 4.9% were
located within 1 Kb of 5 exons. Table 1C presents the enrichment for the overall number of exact matches to consensus binding motifs found
in the TFBS. Note that some TFBS contained more than 1 binding motif. An additional study considered inexact matches to the p53 sites.
of well-characterized genes represent novel roles for most exon of a gene (Figure 1). Only 22% of the TFBS
regions are located in a canonical position at the 5the monitored TFs. The previously described Sp1 regu-
lation of the superoxide dismutase gene (SOD1) (Minc end of well-characterized genes. The location of TFBS
regions within or 3 to well-characterized genes sug-et al., 1999), the cMyc-regulated macrophage migration
inhibitory factor (MIF) (Watson et al., 2002), a collection gests that they may represent distal regulatory elements
(e.g., enhancers or silencers) or promoters for noncod-of 17 cMyc-responsive genes (Menssen and Hermeking,
2002), and a set of putative p53 targets (Kannan et al., ing transcripts.
The 33 TFBS regions positioned either within or down-2001) represent the sum of the previously characterized
genes associated with these TFs along chromosomes stream of the last exon of annotated genes on chromo-
somes 21 and 22 are interesting due to the potential for21 and 22. (3) The observation of 69 Genscan-predicted
genes with cMyc and/or Sp1 binding sites at their 5 antisense transcripts to overlap the 3 UTRs of these
genes (Table 2). This observation is related to the pres-ends, along with RNA transcription data, supports the
existence of these ab initio predictions. (4) Sites located ence of short (100 bp) conserved stretches within the
5 and 3 UTRs of a large number of mammalian genesoutside of known annotations are likely to represent
regulatory regions for novel transcripts based on the and the resulting suggestion that these conserved se-
quences are involved in mRNA stability and possiblyRNA transcription and EST data. Out of 21 (10%) of
such regions tested, 19 are associated with transcribed form duplexes with antisense transcripts (Lipman, 1997).
Similarly, 1600 sense/antisense gene pairs in the genome,regions by RT-PCR (data not shown). (5) Despite the
enrichment in the predicted TFBS for characteristics most of which primarily overlap 5 and 3 noncoding
regions, have recently been identified using a computa-typically associated with promoter regions (proximity to
CpG islands and 5 exons, presence of known binding tional approach (Yelin et al., 2003). Most importantly, all
but two of the 33 TFBS located within or at the 3 endsmotifs), many of the remaining TFBS identified in this
study lack such properties, suggesting that TFs may be of well-characterized genes (Table 2) are positioned just
upstream of possible novel transcripts based either ontethered to these genomic locations independently of
their sequence-specific DNA binding properties. our earlier reported RNA transcription mapping data
(Kapranov et al., 2002) or mapped ESTs. Of the 3 TFBS
regions listed in Table 2, 27% (9/33) are situated in genesRelationship of TFBS to RNA Transcripts
having one or more of the same transcription factors atGiven that many of the TFBS sites were clustered to-
the 5 end.gether, they were grouped into TFBS regions, defined
as maximal sets of TFBS such that neighboring sites
are separated by less than 1 Kb. The 1157 TFBS sites Biochemical and Computational Verification
of Novel Transcriptsyielded 866 regions, 305 and 561 on chromosomes 21
and 22, respectively. Interestingly, 36% of these regions The structure and sequence of a subset of these novel
transcripts were characterized. Prior to collecting exper-are situated within known genes or proximal to the 3
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Figure 1. Classification of TFBS Regions
TFBS regions for Sp1, cMyc, and p53 were
classified based upon proximity to annota-
tions (RefSeq, Sanger hand-curated annota-
tions, GenBank full-length mRNAs, and En-
sembl predicted genes). The proximity was
calculated from the center of each TFBS re-
gion. TFBS regions were classified as follows:
within 5 kb of the 5 most exon of a gene,
within 5 kb of the 3 terminal exon, or within
a gene, novel or outside of any annotation,
and pseudogene/ambiguous (TFBS overlap-
ping or flanking pseudogene annotations,
limited to chromosome 22, or TFBS regions
falling into more than one of the above cate-
gories).
imental data, preliminary evidence for the presence of that are located on the 3 end of the well-characterized
gene appear to be located 5 of the overlapping novelnovel transcripts was derived from chromosome 21 and
22 RNA maps (Kapranov et al., 2002) and from the pub- transcript, which suggests that these transcripts may
be regulated by these factors and in precisely the samelicly available EST data. Novel transcripts were verified
using RT-PCR analyses in 9/11 regions and were found way as protein coding genes.
Additional supporting evidence that these TFs mayto have little coding capacity (less then 50 amino acids).
Northern hybridization analysis of these isolated tran- be regulating antisense transcripts was found by relating
them to full-length mRNAs and ESTs with confidentlyscripts with strand-specific oligonucleotides or ribo-
probes indicate that they are polyadenylated, in some assignable strandedness (determined from splicing and
polyadenylation sites and signals). 1782 clusters of tran-cases spliced, and are present as single and multi-exon
isoforms ranging in size from 800 bp to 9 Kb (Supple- scripts were formed of well-oriented sequences from
public databases aligning to chromosomes 21 or 22.mental Figure S3 on Cell website). Together with the
strand-specific RT-PCR data, this suggests that several Among these clusters, there was a significant associa-
tion (chi-square p value  1015) between the propertyof them might also be antisense to known genes, such
as, for example, EP300 (Figures 2C and 2D), UBASH3A of proximity to a noncanonical TF and the property of
having evidence for transcription on the opposite strand.(Supplemental Figures S2A and S2B online), SEC14L2
(Supplemental Figures S2C and S2D), and others. In this context, a noncanonical TF is one not located at
the 5 end of a known gene and evidence for transcrip-The Ewing sarcoma gene (EWSR1) (Plougastel et al.,
1993), the tumor suppressor gene, EP300 (Gayther et tion on the opposite strand is based on public sequence
data. Twenty-one percent (363) of these transcript clus-al., 2000), and mitogen-activated protein kinase MAPK1
(Gonzalez et al., 1992) on chromosome 22 illustrate po- ters are made up of sense antisense pairs, 44% (161)
have an associated noncanonical TF. Of the 161 sensetential utilization of common TFs to regulate both well-
characterized and novel transcripts (Figure 2). Sequence antisense pairs that have a noncanonical TF, 52% con-
tain at least one site conserved between the humananalysis of the novel transcripts that overlap EWSR1
and EP300 indicate that they are spliced RNAs. Interest- and mouse genomes based on BlastZ human-mouse
alignments (Schwartz et al., 2003).ingly, a conserved region in the 3 UTR of the EWSR1
gene is consistent with the evidence of antisense regula-
tion of this gene (Lipman, 1997). The EP300 gene is a Differential Expression Patterns
of Novel Transcriptsstriking example (Figures 2C and 2D), having a TFBS
region 17 kb away from the 3 end and a novel transcript To address the issue of whether the observed overlap-
ping noncoding transcripts are biologically important,that splices from this site into the 3 end of the gene.
Additionally, overlapping novel transcripts from the we examined whether some of them exhibited a repro-
ducible and coordinated program of differential expres-genes encoding nuclear protein UBASH3A (Supplemen-
tal Figures S2A and S2B), phosphatidylinositol transfer- sion correlated with the companion coding transcripts.
The expression profiles of the poly(A) cytosolic RNAlike protein SEC14L2 (Supplemental Figures S2C and
S2D), TBC/rabGAP domain protein EPI64 (Supplemental fraction were monitored during the response of a pluri-
potent human germ cell tumor-derived cell line, NCCIT,Figures S2E and S2F), guanine-nucleotide exchange
factor TIAM1 (Supplemental Figures S2G and S2H), which undergoes retinoic acid (RA)-induced differentia-
tion into keratin- and neurofilament-positive somaticKIAA0376 protein (Supplemental Figures S2I and S2J),
and GTSE1 (Supplemental Figures S2K and S2L) were cells (Damjanov et al., 1993). Empirically derived tran-
scriptional maps of NCCIT using the chromosome 21verified by RT-PCR and/or Northern blot analyses (Sup-
plemental Figure S3). In many of these cases, the TFBS and 22 genome tiling arrays during various stages of
Transcription Factors on Chromosomes 21 and 22
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Table 2. Location of 3 TFBS Regions and Proximal Annotated Gene
Novel
Transcriptome Novel
Start Stop 3 TFBS 3 Flanking Gene Evidencea EST Evidenceb 5 TFBSc
Chr. 21
26953700 26954500 cMyc C21orf6 gene (NM_016940) Y — cMyc
30550300 30551000 cMyc, Sp1 C21orf59 mRNA (NM_017835) Y AI872268 —
31250700 31250800 cMyc IL10RB gene (NM_000628) Y D20421 Sp1, cMyc
32324600 32326500 cMyc ENST00000290310 Y — —
33978900 33980000 cMyc, Sp1 C21orf18 mRNA (NM_017438) Y — —
34099000 34099500 cMyc CBR3 (NM_001236) Y AI183799 Sp1, cMyc
35012900 35013300 Sp1, p53 DSCR5 (NM_016430) Y — cMyc
35170600 35171200 cMyc, Sp1 DSCR3 (NM_006052) Y BI769073 Sp1, cMyc
37611800 37612200 cMyc B3GALT5 (NM_006057) Y — —
40264500 40265500 cMyc ABCG1 (NM_004915) Y — cMyc
40328700 40329500 cMyc TFF1 (NM_003225) Y AA632099 —
40415000 40418100 cMyc, Sp1 UBASH3A (NM_018961) Y — cMyc
41144500 41145300 cMyc, Sp1 CRYAA (NM_000394) Y — —
42093800 42094500 Sp1 ENST00000291578 Y BG679497 —
43871400 43871600 cMyc PCBP3 (NM_020528) Y — —
Chr. 22
15149900 15150300 cMyc MIL1 (NM_015367) Y — Sp1d
16100000 16100900 cMyc SLC25A1 (NM_005984) Y — Sp1
18699300 18699600 cMyc SDF2L1(NM_022044) N — Sp1, cMyc
20933500 20934100 cMyc MIF (NM_002415) N — —
21036700 21037300 cMyc HS322B1A (NM_015371) Y — —
22328100 22328500 Sp1 CRYBB2 (NM_000496) Y — —
26259200 26260100 cMyc KREMEN (NM_032045) Y — —
27354700 27355700 cMyc OSM (NM_020530) Y — cMyc
28445500 28446000 cMyc Sanger gene Y — —
(AC005003.C22.4)
28775000 28775800 p53 Sanger gene dJ694E4.C22.2 Y — Sp1, cMyc
32590700 32592300 Sp1 RASD2 (NM_014310) Y — —
32773900 32774700 Sp1, p53 Sanger gene dJ41P2.C22.1 Y — —
36399500 36399700 cMyc SYNGR1 (NM_004711) Y BE348322, —
H67984
38412300 38412400 cMyc Sanger gene dJ979N1.C22.1 Y — cMyc
47554600 47555500 Sp1 MAPK8IP2 (NM_012324) Y — —
47563700 47564300 cMyc ARSA (NM_000487) Y — Sp1
47689000 47689300 Sp1 ACR (NM_001097) Y — —
47690600 47691600 Sp1, p53 ACR (NM_001097) Y — —
a Evidence of novel transcription based upon RNA transcription mapping data (Kapranov et al., 2002).
b Evidence of transcription based upon EST data.
c Identity of 5 TFBS of the indicated gene, if present.
d Relative to largest annotated transcript.
Coordinates of TFBS regions located 3 to annotated genes (RefSeq, Sanger, and Ensembl). The TFs detected in these regions and the gene
to which the region is proximal are indicated in the third and fourth columns. Evidence of novel transcription based on transcriptome evidence
(Kapranov et al., 2002) and on EST data is determined by inspecting for possible transcriptional activity and by the alignment of antisense
ESTs outside of annotated exons. The last column indicates if a TFBS was also detected at the 5 end of the proximal gene.
differentiation were generated with 4, 24, 96, and 366 evaluated. From the observed fold-change, a correlation
between coding and noncoding paired transcriptshr of stimulation with 10 M of retinoic acid. When all
time points are considered, approximately 6% of the was computed.
The average correlation was significantly larger thanprotein-coding and 6% of the noncoding RNAs were
induced greater than 2-fold in response to retinoic acid. can be explained by chance alone (Figure 3), suggesting
the existence of a subpopulation of transcripts whereIn addition, approximately 9% of protein-coding and
17% of noncoding RNAs are downregulated more than the coding and noncoding transcripts are positively cor-
related. The positive correlation is consistent with a co-2-fold in response to retinoic acid. Thus, the noncoding
RNA population responds to RA-induced differentiation ordinated regulation of coding and noncoding transcrip-
tion. We note that of approximately 10% (21/214) of thein a manner very similar to the response of the coding
genes. overlapping coding/noncoding gene pairs that respond
during the timecourse of retinoic acid stimulation, onlyProbes overlapping coding/noncoding transcript pairs
identified from the public databases were used to moni- a few show anti-correlated regulation, which is expected
if, for example, the noncoding transcripts are silencingtor potential coordinate regulation. For each transcript
partner of a coding/noncoding pair, as well as for each the coding transcripts. The positive coordinated expres-
sion of coding and noncoding transcripts points to atime point, the median fold-change with respect to a
control for all probes interrogating the transcript was supportive function for the expression of the responding
Cell
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Figure 2. Overlapping Coding and Noncoding Transcripts Potentially Regulated by the Same Transcription Factors
Positions of 5, 3, and internal binding sites for Sp1 (red), c-Myc (green), or p53 (blue) are shown for the EWSR1 (A and B), EP300 (C and D),
and MAPK1 (E and F) genes. The exon-intron structure of each gene, known isoforms, all currently available human EST annotations, and
the tight subset of human-mouse BLASTZ alignments are shown on the June 2002 version of the genome. The locations of experimentally
determined novel, noncoding transcripts are indicated by the arrows. Oligonucleotide or RNA probes used in the Northern experiments in
Supplemental Figure S3 were derived from these regions. In the cases of EWSR1 and EP300, the presence of novel antisense transcripts is
also supported by spliced ESTs AI687358 (EWSR1) and AW511192 and AA889875 (EP300). The enlarged views of the regions containing
noncoding transcripts are shown on the right along with earlier reported RNA transcription mapping data (Kapranov et al., 2002).
genes and also shows that such transcription of noncod- of regulatory elements (tens of thousands), which ap-
ing genes is not a random and unguided response. A proaches the estimated number of annotated coding
second interesting observation stemming from this re- genes. This unexpected number of TFBS further high-
sult is that the locations of these polyadenylated coding lights the presence of the many as yet unannotated
and noncoding transcripts are destined for the cytosol, genes. However, many of the TFBS are in accord with
from which they were isolated. The models recently pro- expectations in that we observed statistically significant
posed by Carmichael (Carmichael, 2003) and others enrichment of these TFBS near 5 promoters of coding
point to a nuclear location for the possible negative genes and CpG islands as well as enrichment of their
regulatory functions of long antisense RNAs (i.e., non- expected consensus sequence compared to random
siRNAs and non-miRNAs). chance. TFBS tend to cluster along the genome as might
be expected of modular genetic control regions. For
example, we observe a very strong overlap of cMyc andDiscussion
Sp1 binding regions, in accord with several character-
ized promoters with both cMyc and Sp1 sites.Expected and Unexpected Locations
A second striking observation is that TFBS bound toof Transcription Factor Binding Sites
classically defined promoter regions represent a clearin the Human Genome
minority of genomic binding sites in living cells. AlthoughAn unbiased mapping of Sp1, cMyc, and p53 along hu-
it is highly likely that the specific genomic profile ofman chromosomes 21 and 22 has identified a surpris-
transcription factor binding will vary considerablyingly large number of transcription factor binding sites
among different cell types, we believe that the transcrip-(TFBS) that are occupied in living cells (Figure 4). These
tion factors and cells used in the experiments here areTFBS were identified using a stringent p value threshold,
representative. Thus, we strongly suspect that the re-and direct verification experiments indicate that few of
sults we have obtained for p53, cMyc, and Sp1 willthe identified sites are false positives and that the num-
generally apply to other transcription factors and otherber of true sites is likely to be higher. Strikingly, extrapo-
cell types. These results emphasize the value of usinglation of these results for only three transcription factors
to the entire human genome provides a possible number tiled microarrays representing complete genomic re-
Transcription Factors on Chromosomes 21 and 22
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Although the presence of a TFBS does not necessarily
imply a direct effect of the transcription factor on the
expression of the gene, it is striking that so many non-
coding RNAs are associated with TFBS regions and that
roughly comparable numbers of binding sites for a given
factor are found at noncoding and protein-coding genes.
While the contribution of individual binding sites to the
transcription of the nearby gene will certainly vary from
gene to gene, this issue is similar for both protein-coding
and noncoding genes. Thus, it is difficult to imagine that
hundreds of binding sites in the vicinity of the noncoding
RNAs represent random and functionally meaningless
occurrences. Furthermore, a significant number of non-
coding transcripts are regulated by retinoic acid, and
coregulation of overlapping noncoding and protein-cod-
ing genes occurs at a significantly higher frequency than
expected by chance. Such coregulation of overlapping
genes was unexpected, and it seems very unlikely that
it represents transcriptional noise.
Our analysis was limited to a set of three transcription
Figure 3. Correlation of Coding/Noncoding Transcript Pairs factors and one environmental induction condition.
Thus, it is completely expected that not all noncodingCoding/noncoding transcript pairs were formed from public EST
and mRNA databases, and correlation in fold-change between the RNAs are associated with the transcription factors
coding and noncoding transcripts was monitored. Among the 29% tested and that only a minority (20%) of the noncoding
of the pairs that exhibited differential behavior in the experiment, RNAs are regulated by retinoic acid. These considera-
the average Pearson correlation was 0.34. To assess significance,
tions apply equally to protein-coding and noncodinga bootstrap approach was used in which the time points were ran-
genes, and these two sets of genes are similar withdomly permuted and the correlation was recomputed, yielding a
respect to the functional criteria tested. As the limitedtwo-tailed p value of less than 0.0002. The figure presents a histo-
gram of the 5000 bootstrapped average correlations, and the red set of transcription factors and environmental condi-
line represents the actual observed average correlation. tions tested were chosen without preconceived notions
of the results, it is highly likely that the general nature
of the observations extend to other transcription factorsgions as opposed to arrays restricted to promoters or
and other conditions of environmental change. Takenother selected genomic regions.
together, our results strongly suggest that the large pop-
ulation of noncoding RNAs are expressed and regulatedFunctional Attributes of Noncoding RNAs Suggest
by similar molecular mechanisms that are involved inthat They Are Expressed and Regulated
the control of protein-coding RNAs. Furthermore, theSimilarly to Protein-Coding Genes
specific functional attributes associated with such aAlthough a large number of novel, noncoding RNAs have
large number of noncoding RNAs on chromosomes 21been detected in the human genome (Chen et al., 2002;
and 22 (and by extension the entire human genome)Kapranov et al., 2002; Saha et al., 2002), it has been
strongly argue that many of these RNAs have biologicalunclear whether these RNAs represent transcriptional
functions and are not physiological artifacts.noise or functional entities. Here, we demonstrate three
functional attributes of these noncoding transcripts.
First, many of the noncoding RNAs are associated with Potential Biological Functions of Noncoding RNAs
There are many possible biological functions of the non-nearby TFBS, and we note that Sp1 typically binds and
functions at proximal 5 promoter regions. Second, coding RNAs, and elucidating these functions will re-
quire detailed molecular and genetic analysis of specificmany of the TFBS regions associated with human non-
coding RNAs are conserved in the mouse genome. transcripts. One potential function is suggested by the
numerous noncoding, antisense transcripts that overlapThird, a significant number of the identified noncoding
transcripts are regulated by retinoic acid-induced differ- RNAs corresponding to protein-coding genes. Many re-
ports demonstrate that naturally occurring antisenseentiation. Presumably, much of this transcriptional regu-
lation is mediated by binding of retinoic acid receptors transcription regulates prokaryotic gene expression
(Wagner and Simons, 1994), and there has been an in-and/or transcription factors induced by these receptors
in the promoter regions of the novel transcripts. Impor- creasing appreciation that antisense transcription plays
important functions in eukaryotic cells (Yelin et al., 2003).tantly, if one compares the sets of non-coding and well-
characterized protein-coding RNAs on chromosomes Examples of this include X chromosome inactivation
(Brockdorff et al., 1992; Brown et al., 1992), small non-21 and 22, the number of genes bound by an individual
transcription factor and the number of genes regulated coding RNA control of gene silencing in C. elegans (Ash-
rafi et al., 2003; Kamath et al., 2003; Lee and Ambros,by retinoic acid are roughly comparable. Thus, the non-
coding transcripts share important functional character- 2001) and plants (Hamilton and Baulcombe, 1999), gene
imprinting (Reik and Walter, 2001; Sleutels and Barlow,istics of protein-coding genes, and indeed the two sets
of transcripts cannot be distinguished by the functional 2002), and more recently, evidence of individual gene
regulation (Kramer et al., 2003; Solymar et al., 2002). Incriteria used here.
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Figure 4. Chromosomal Maps of TFBS
Positions of the TFBS detected for p53, Sp1, and cMyc along chromosomes 21 and 22. The track labeled “known genes” depicts 5 ends of
genes from the “known genes” track on the UCSC genome browser and is based on SWISS-PROT, TrEMBL, GenBank mRNA, and RefSeq
annotations. The “internal/3 TFBS” track presents the locations of the TFBS located within or 3 to annotated genes, as reported in Table 2
and Supplemental Table S2 online.
addition to these examples, studies undertaken to sur- entire genome. Mechanistically, such coregulation may
be related to our observation that a common transcrip-vey the prevalence of noncoding transcripts on a ge-
nome-wide basis have revealed the widespread occur- tion factor is often associated with promoters of both
the protein-coding and noncoding transcript of an over-rence of antisense transcripts (Lehner et al., 2002;
Patankar et al., 2001; Wagner and Flardh, 2002; Yelin et lapping pair. Alternatively, coregulation may be achieved
via a large-scale chromatin domain that includes bothal., 2003). The empirically derived results of this study
indicate a higher proportion of overlapping gene pairs of the overlapping transcripts and that is either accessi-
ble or inaccessible in a regulated fashion. Why are thesethan the 8% based on computational analysis (Yelin et
al., 2003). The primary reason for this discrepancy may noncoding transcripts found in the cytoplasm if they are
synthesized coordinately with the coding transcripts inbe that intron regions were not considered in this earlier
study and that many regions of the genome are tran- the nucleus and have the potential to form double-
stranded structures? It may be that the noncoding tran-scribed but are not represented in the annotations or
EST databases. As our results indicate that many non- scripts do not directly regulate the coding gene, but are
rather involved in the same pathway as the coding genecoding, antisense RNA are associated with transcription
factors and are transcriptionally regulated, some of itself. Overlapping coding/noncoding gene architecture
may serve to facilitate the concordant regulation of boththese antisense RNAs may have biological functions
relating to a classical antisense mechanism. However, groups of transcripts similar to an RNA-based signaling
network model (Mattick, 2001).the apparent absence of negative correlation in the ex-
pression levels of coding-noncoding pairs suggests that The human genome has tens of thousands of noncod-
ing transcripts, and as a general class, they behavethe functional relationship of antisense transcripts is
more complicated than a relatively simple model of re- similarly to protein-coding genes with respect to the
presence of TFBS and the ability to be regulated byciprocal inhibition.
Our unexpected observation that coregulation of environmental signals. By analogy with protein-coding
genes, it seems likely that some, and perhaps many, ofoverlapping pairs of coding and noncoding transcripts
occurs more frequently than expected by chance is sug- the noncoding RNAs may have biological functions that
are unrelated to those of overlapping or neighboringgestive of a coordinated expression strategy across the
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trix Transcriptome data (Kapranov et al., 2002) and/or EST evidenceprotein-coding genes. In this regard, may of the noncod-
were selected for strand-specific RT-PCR. For each such region,ing RNAs do not map near protein-coding genes, yet
2 RT primers separated by 16–254 bp and 2 pairs of nested PCRthey have similar properties to noncoding RNAs that
primers lying upstream from the RT primers were selected using
are part of overlapping pairs. Lastly, it is possible that Oligo 6 (Molecular Biology Insights, Inc.). Jurkat cytosolic poly(A)
biological functions associated with some of these non- RNA was treated with 0.8 Units of RNase-free DNaseI (Roche) per
1 g of RNA in 1 1-PHOR-ALL buffer (Amersham-Pharmacia) forcoding RNAs might not be due to the RNA products per
20 min at 37	C, purified using RNeasy kit (Qiagen), and ethanol-se, but rather to the transcriptional process itself, which
precipitated. For each region, an RT reaction was performed on 100is likely to alter chromatin structure within and adjacent
ng of DNase I-treated poly(A) RNA with a pool of 2 RT primersto the transcribed regions. These data encourage future
each at 0.9 M, under the following conditions in the GeneAmp9600
mechanistic investigations and discussions concerning cycler (Perking Elmer): RNA and primers were heated to 70	C for
the definition of a gene, the precise role of transcription 10 min, followed by a ramp to 42	C or 52	C for 20 min, at which
factor binding proteins, and the possible reconsidera- point 5 Superscript II First Strand buffer (Invitrogen), DTT, and
four dNTPs were added to the following final concentrations of 1,tion of current concepts of the structure and functioning
10 mM and 0.5 mM, respectively. After 2 min at this temperature,of a eukaryotic genome.
200 Units of Superscript II (Invitrogen) were added, followed by a
60 min incubation at 42	C or 52	C. RT was inactivated by a 15Experimental Procedures
min incubation at 70	C. The mRNA template was degraded using a
combination of RNase, DNase-free (Roche), and RNase H (In-Chromatin Immunoprecipitation Protocol
vitrogen). One-third of each reaction was used for two rounds ofCell lines HCT116 (ATCC CCL-247) and Jurkat (ATTC TIB-152) were
PCR with nested primers. Each reaction contained 0.36 M of eachgrown to a density of 0.4  106 cells/ml. HCT116 cells were treated
PCR primer, 1 Taq Gold buffer, 0.2 mM dNTPs, 1.5 mM MgCl2,with 5 mU/ml of bleomycin for 24 hr to induce expression of wild-
1.0 U Taq Gold Polymerase (Perkin Elmer) in a final volume of 50type p53. Cells were fixed with 1% formaldehyde for 10 min at room
l. PCR amplification was performed after an initial step of 9 mintemperature, with occasional swirling. Glycine was added to a final
at 94	C for 40 cycles of 30 s at 94	C, 30 s at 55	C, and 2 min atconcentration of 0.2 M and the incubation was continued for an
60	C, with a final extension of 10 min at 60	C. A second round ofadditional 5 min. Cells were collected and washed with ice-cold
PCR amplification was performed with nested primers on 2 l ofPBS three times, cell lysis buffer (10 mM Tris-Cl [pH 7.5], 10 mM
the first round reaction under the same conditions. The followingNaCl, 0.5% NP-40, 1 mM PMSF) three times, and resuspended in
controls were performed: no reverse transcriptase to control for DNASDS lysis buffer (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% SDS,
contamination, no RT primers to control for self-priming of RNA.1 mM EDTA). the cells were disrupted by sonication on ice. The
chromatin solution was clarified by centrifugation at 15,000 g at 4	C
for 10 min. The average DNA fragment size was 2.5 kb. The chroma- Differentiation of NCCIT Cell Line
tin solution was diluted with IP dilution buffer (20 mM Tris-Cl [pH NCCIT cell line was obtained from ATCC (CRL-2073), grown in RPMI
8], 1 mM EDTA, 1% Triton X-100, and 150 mM NaCl, protease inhibi- 1640 supplemented with 10% FBS at 37	C, humidified atmosphere
tors) and pre-cleared with protein A Sepharose beads for 15 min. with 5% CO2. Differentiation was induced by 10 M all-trans-Reti-
The pre-cleared diluted chromatin sample was incubated with 10 noic acid (Calbiochem, California). In 96 hr and 336 hr experiments,
l of anti-GST, anti-Sp1, anti-c-Myc, anti-p53 (DO1), or anti-p53(FL) medium with RA was replaced every 72 hr. RNA isolation, labeling,
for 3 hr followed by the addition of protein A Sepharose beads for and hybridization to Chrom21_22 arrays were performed as de-
an additional 3 hr. The beads were washed once with the IP dilution scribed previously (Kapranov et al., 2002).
buffer, twice with 20 mM Tris-Cl (pH 8), 2 mM EDTA, 1% Triton
X-100, 150 mM NaCl, 1 mM PMSF, once with 20 mM Tris-Cl (pH 8), Analysis of Tiling Array Data
2 mM EDTA, 1% Triton X-100, 0.1% SDS, 500 mM NaCl, 1 mM Arrays were quantile-normalized within treatment/control replicate
PMSF, and once with 10 mM Tris-Cl (pH 8), 1 mM EDTA, 0.25M LiCl,
groups (Bolstad et al., 2003) and then all were scaled to have a
1% NP-40, 1% deoxycholate. The immunoprecipitated material was
median feature intensity of 1000. (PM, MM) intensity pairs were
eluted from the beads by heating for 15 min at 65	C in 25 mM Tris-
mapped to the genome using exact 25-mer matching. For each
Cl (pH 7.5), 10 mM EDTA, 0.5% SDS. To reverse the crosslinks,
genomic position to which a probe pair mapped, a data set was
samples were incubated with 1.5 g/ml Pronase at 42	C for 2 hr
generated consisting of all (PM, MM) pairs mapping within a window
followed by 65	C for 5 hr. The samples were then extracted with
of 
500 bp. A Wilcoxon Rank Sum test was applied to the transfor-
phenol chloroform isoamyl alcohol followed by chloroform, ethanol
mation log2(max(PM-MM,1)) for data from the six treatment and sixprecipitated in the presence of glycogen, and resuspended in TE
control arrays within the local data set, testing the null hypothesisbuffer. The resulting precipitated DNA was amplified and hybridized
of equality of the two population distribution functions against theto the chromosome 21 and 22 arrays.
alternative of a positive difference in location between the probabil-
ity distribution of the treatment and that of the control. The WilcoxonQuantitative PCR Verification
test was applied in a sliding window across the genome. Genomicof Array-Detected Binding Sites
positions belonging to TFBS were defined by applying a p valueQuantitative real-time PCR experiments were performed using the
cutoff of 105, resultant positions separated by 500 bp wereApplied Biosystems 7700 sequence detector based on SYBR Green
merged to form a predicted TFBS. Predicted TFBS were producedI fluorescence. Reactions were carried out in 10 l using SYBR
by this method for each TF against each of the controls (skippinggreen PCR master mix according to the manufacturer’s protocol.
the immunoprecipitation step and using an antibody to GST), theCycling was for 10 min at 95	C, followed by 40 cycles of 95	C,
resulting two sets of predicted TFBS were merged together to form30 s, 60	C, 45 s, 72	C, 45 s. The fold-enrichment value for each
a nonredundant set of TFBS. All data are accessible at http://transcription factor bound to a particular region of DNA was esti-
transcriptome.affymetrix.com/publication/tfbs.mated as V/V. Vwas calculated by subtracting the cycle thresh-
old (Ct; defined as the cycle at which the fluorescence signal is
Calculation of TF Motif Enrichment in Array-Detected Sitesstatistically significant over background) average of input DNA from
The degree of enrichment for binding motifs in the predictedthe Ct average for the immunoprecipitated DNA; this net Ct value
TFBS was estimated using the patterns GG[G/T]G[C/T]GGG andwas then used as an exponent for the base 1.9 (1.9 being the mean
CA[C/T]G[T/C]G for Sp1 and cMyc, respectively. For p53, whichprimer slope). The same procedure was repeated to obtain the nega-
binds as two dimers, the search was for the pattern X[0-14N]X wheretive control region value (V).
X  PuPuPuC(A/T)(T/A)GPyPyPy. TFBS less than 1 Kb in length
were expanded equally in each direction to have length 1 Kb, and theRT-PCR Verification of Noncoding Transcripts
resulting regions were repeat masked and scanned for the knownGenomic regions proximal to internal or 3 TFBS and exibiting evi-
dence of transcription outside of annotated exons based on Affyme- binding motifs. This observed count of motifs was compared with
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the number expected by chance, which was computed by determin- randomly permuted and the correlation was computed; this was
repeated 5000 times and a null distribution was estimated. Whening the rate of occurrence of binding motifs in the nonrepetitive
sequence of chromosomes 21 and 22 and multiplying by the amount assessed in light of the null model, the observed correlation had a
two-tailed p value of less than 0.0002. The results were very similarof nonrepetitive sequence in the expanded TFBS. 90, 383, and 1
binding sites are found for Sp1, cMyc, and p53, respectively; the in terms of size and significance of the correlation when Spearman
correlation was used in place of Pearson correlation.expected counts at random are 12, 145, and 0.04, representing an
enrichment of 7.5-, 2.6-, and 25-fold for Sp1, cMyc, and p53 (we
note that given there was only one detected p53 binding motif the Acknowledgments
last fold-enrichment will have a higher standard error).
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